Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

No, not at all. While I think we have a pretty fantastic drug approval process (that got a frustratingly bad rap for all the wrong reasons during covid), long term consequences will remain to be seen.

It's just that these considerations run up against a very solid understanding of how much death is caused by being overweight and having high blood pressure.

Right now, Ozempic does not have to be very good, to be most likely a lot better than the alternative.



Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: